Company intelligence / Profile preview

Kagu Consulting

Ownership: Private
Development stage: Other

Overview

Kagulex provides advisory and consulting services to the biotechnology and pharmaceutical industries, specializing in due diligence, clinical development planning, CMC management for small molecules and biologics, regulatory writing for MAA/NDA/IMPD submissions, and product development. The company has supported hundreds of clients over 20+ years across multiple therapeutic areas.

Therapeutic areas: Metabolic DisordersPulmonologyImmunologyDermatologyCardiovascularOphthalmologyNeurologyInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Consulting

Beyond the preview

Go deeper on Kagu Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kagu Consulting.

Explore the full profile